SCHEMBL7510288

SCHEMBL7510288

Cc1c(Cl)cccc1-c1oc(Cc2ccccc2)nc1-c1ccc(S(C)(=O)=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 13/20 0.48
▸ NR4A2 P43354 4/20 0.46
▸ RXRA P19793 2/20 0.44
▸ RXRB P28702 2/20 0.44
▸ RXRG P48443 1/20 0.44
▸ NR4A1 P22736 1/20 0.43
▸ NR4A3 Q92570 1/20 0.43
▸ PTGS1 P23219 3/20 0.42
▸ HSD11B1 P28845 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7510702 0.92 PTGS2 (0.48) PTGS2NR4A2RXRARXRBRXRG
SCHEMBL7511828 0.92 NR4A2 (0.55) PTGS2NR4A2RXRARXRBRXRG
SCHEMBL7499042 0.91 NR4A2 (0.45) PTGS2NR4A2RXRARXRBRXRG
SCHEMBL7506065 0.88 PTGS2 (0.48) PTGS2NR4A2RXRARXRBPTGS1
SCHEMBL7511138 0.87 PTGS2 (0.49) PTGS2NR4A2RXRARXRBRXRG
SCHEMBL7507004 0.87 PTGS2 (0.45) PTGS2NR4A2RXRARXRBRXRG
SCHEMBL7500803 0.86 RXRA (0.54) PTGS2NR4A2RXRARXRBRXRG
SCHEMBL7503014 0.86 PTGS2 (0.48) PTGS2NR4A2RXRAPTGS1ALDH1A1
SCHEMBL7508948 0.85 PTGS2 (0.47) PTGS2NR4A2RXRARXRBNR4A1
SCHEMBL7506181 0.84 RXRA (0.46) PTGS2NR4A2RXRARXRBNR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 — — EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 — — US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 — — EP disclosed
US-5719163-A ARTHRITIS G.D. SEARLE & CO. (US) 1998-02-17 — — US disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 — — WO disclosed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 — — EP disclosed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 — — WO disclosed
Send feedback